Fundraising Fox
Find your path to Lauren
Sign up to see every warm intro you have to Lauren
- Paths you didn't know you had: your email and LinkedIn already hold routes to Lauren. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Lauren Mifflin joined Frazier Life Sciences in 2023 as a Principal of Company Creation and is CEO/Co-Founder of Counterakt Therapeutics. She previously served as COO of Hillstar Bio, was a venture partner at 82VS (the venture studio of Alloy Therapeutics), and held fellow and operating associate roles at 5AM Ventures, where she worked with the founding teams of Entrada Therapeutics and Nido Biosciences. Earlier she was a health tech investor at Jump Capital and a consultant at Monitor Group/Monitor Deloitte, and she holds a Ph.D. and M.M.Sc. from Harvard, an M.B.A. from the University of Chicago, and undergraduate degrees from the University of Pennsylvania/Wharton.
Invests in
Biotech
Deals · 1
Aldebaran TherapeuticsBoard seat
via Frazier Life Sciences · filed Mar 2022 · $1.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Sudo Bio
Investor
Counterakt Therapeutics
Sources: SEC Form D filings · the firm's website.
Colleagues at Frazier Life Sciences
Frequently asked questions
- Who is Lauren Mifflin?
- Lauren Mifflin joined Frazier Life Sciences in 2023 as a Principal of Company Creation and is CEO/Co-Founder of Counterakt Therapeutics. She previously served as COO of Hillstar Bio, was a venture partner at 82VS (the venture studio of Alloy Therapeutics), and held fellow and operating associate roles at 5AM Ventures, where she worked with the founding teams of Entrada Therapeutics and Nido Biosciences. Earlier she was a health tech investor at Jump Capital and a consultant at Monitor Group/Monitor Deloitte, and she holds a Ph.D. and M.M.Sc. from Harvard, an M.B.A. from the University of Chicago, and undergraduate degrees from the University of Pennsylvania/Wharton.
- Where does Lauren Mifflin work?
- Lauren Mifflin is Principal of Company Creation at Frazier Life Sciences.
- What does Lauren Mifflin invest in?
- Lauren Mifflin invests in Biotech.
- What boards does Lauren Mifflin sit on?
- Lauren Mifflin holds tracked board seats at Aldebaran Therapeutics, Sudo Bio.
- What companies has Lauren Mifflin invested in?
- Investments tracked here include Counterakt Therapeutics.
About this profile. Compiled from public sources — Frazier Life Sciences's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights